Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of AgeDavid Hosking, A.J.P. Yates, Desmond Thompson et al.|New England Journal of Medicine|1998Cited by 487
Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal WomenPernille Ravn, Claus Christiansen, Giovanni Cizza et al.|Journal of Bone and Mineral Research|1999Cited by 455
Comparison of Weekly Treatment of Postmenopausal Osteoporosis with Alendronate<i>Versus</i>Risedronate Over Two YearsSydney Lou Bonnick, Anne E. de Papp, Kenneth G. Saag et al.|The Journal of Clinical Endocrinology & Metabolism|2006Cited by 144
Accuracy of Cause‐of‐Death Certification in Hiroshima and Nagasaki, JapanSeymour Jablon, Kiyóhiko Mabuchi, Desmond Thompson et al.|Annals of the New York Academy of Sciences|1990Cited by 12